Why ECPC Matters
The challenge of access to medicines is of crucial importance to millions of Europeans affected by cancer every year. Whilst no one country is immune to access issues, some regions and countries in Europe face greater difficulties than others. Several factors have an impact on access to medicines, from regulatory standards to funding systems and the varying nature of healthcare systems across Europe – all adding to inequalities across Europe. The European Parliament adopted a report, on its own initiative, on the ‘Options for Improving Access to Medicines’ – presenting an opportunity for the European Parliament to take a proactive stance on the issue of access to medicines. It makes several calls for action aimed at EU and Member State institutions to address the most urgent challenges when it comes to access to medicines, stressing the added value of European cooperation.
ECPC Conference and General Assembly 2022
Our annual Congress and General Assembly, the pinnacle of each year for us and our members, will take place the 27 and the 28 of May 2022 in a hybrid mode.
Registration is open until 22 April 2022
Personalised Medicine Booklet
ECPC together with ecancer has launched a new toolkit to provide patients with a comprehensive resource on genetic and genomic tests. The new resource will help patients and their families understanding them and make an informed choice.